Pfizer Inc at Wolfe Research Healthcare Conference (Virtual) Transcript
Okay. I think we've begun here. So thanks for joining us. I'm Tim Anderson. I'm the large-cap pharma and biotech analyst at Wolfe Research.
Today is the first day of our 2 day healthcare conference, where we'll be interviewing different companies in a fireside chat format.
We've got Pfizer with us for this next session. 3 members of the R&D team, Mikael Dolsten, President, Worldwide R&D, Chief Medical Officer. He came to Pfizer through the Wyeth acquisition in 2009. We have Annaliesa Anderson, who is SVP and Chief Scientific Officer in Bacterial Vaccines and Hospitals. She's been with the organization since 2007. We have Charlotte Allerton, SVP and Head of Medicine Design with the company since 1993. And we have Chris Stevo from Investor Relations. And Chris, I think you want to make some opening remarks here.
Yes, I'm not a scientist, so all I'm good for is reading forward-looking statements. So I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |